Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,700 public trials 1,041 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer

NCT06249854

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hallym University Medical Center Anyang-si, Gyeonggi-do, South Korea
  • Pusan National University Yangsan Hospital Yangsan, Gyeongsangnam-do, South Korea
  • Kyung Hee University Hospital Seoul, South Korea
  • Hanyang University Seoul Hospital Seoul, South Korea
View Trial Details
Completed

A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung Cancer

NCT06532032

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • UCI Health Irvine Hospital Irvine, California, United States
  • Cancer and Blood Specialty Clinic Los Alamitos, California, United States
  • University of California Irvine Medical Center Chao Family Comprehensive Cancer Center Orange, California, United States
  • Oncology Hematology Associates Springfield, Missouri, United States
View all 15 locations
View Trial Details
Completed

Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer

NCT02718066

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +32 more
Locations
  • [Site 02] Mayo Clinic Arizona Phoenix, Arizona, United States
  • [Site 11] University of California, San Diego Medical Center La Jolla, California, United States
  • [Site 01] Hematology - Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • [Site 09] H. Lee Moffitt Cancer Center and Research Institute, Inc. Tampa, Florida, United States
View Trial Details
Completed

Efficacy and Safety of 80mg Osimertinib in Patients With Non-small Cell Lung Cancer(NSCLC)

NCT04563871

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • ChungBuk National University Hospital Cheonju, South Korea
  • National Cancer Center Goyang, South Korea
  • Seoul National University Bundang Hospital Seongnam, South Korea
  • Samsung Medical Center Seoul, South Korea
View Trial Details

Related conditions